REQUEST A DEMO
Total
USD $0.00
Search more companies

America Cell Biomedica Sas (Colombia)

Main Activities: Other Ambulatory Health Care Services
Full name: America Cell Biomedica Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

America Cell Biomedica Sas is based in Colombia. The head office is in Bogota D.C.. The company operates in the Other Ambulatory Health Care Services industry. It was established on July 15, 2012. There are currently 28 (2024) people employed by America Cell Biomedica Sas. In its most recent financial highlights, the company reported a net sales revenue increase of 28.92% in 2023. Its total assets grew by 7.07% over the same period. In 2023, America Cell Biomedica Sas’s net profit margin increased by 5.1%.

Headquarters
Cra 21 166 81
Bogota D.C.; Bogota D.C; Postal Code: 1024

Contact Details: Purchase the America Cell Biomedica Sas report to view the information.

Basic Information
Total Employees:
Purchase the America Cell Biomedica Sas report to view the information.
Outstanding Shares:
Purchase the America Cell Biomedica Sas report to view the information.
Incorporation Date:
July 15, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after America Cell Biomedica Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
28.92%
Total operating revenue
28.92%
Operating profit (EBIT)
194.51%
Net Profit (Loss) for the Period
193.16%
Total assets
7.07%
Total equity
16.31%
Operating Profit Margin (ROS)
5.36%
Net Profit Margin
5.1%
Return on Equity (ROE)
8.46%
Quick Ratio
0.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?